2026. Letter to the Editor Regarding the Article "Use of Autologous Dendritic Cell Vaccine CaTeVac in Melanoma Patients: Final Results of the DENDRON-01 Study". Voprosy onkologii. 72, 1 (Mar. 2026), OF-2542. DOI:https://doi.org/10.37469/0507-3758-2026-72-1-OF-2542.